PYXS   $3.7  0.68% Market Closed After Close 3.69 -0.27%

Pyxis Oncology Inc
Total Cash 155.72M
totalCashPerShare 2.642
EBITDA -63.16M
Total Debt 20.87M
quickRatio 9.216
currentRatio 9.531
Total Revenue 16.15M
debtToEquity 12.293
Revenue/Share 0.327
ROA -0.21531
ROE -0.37581003
grossProfits
freeCashflow -14.91M
operatingCashflow -56.55M
earningsGrowth
revenueGrowth
grossMargins 0.97058
ebitdaMargins 0.0
operatingMargins -4.09247
profitMargins 0.0
enterpriseValue 87.95M
forwardPE -3.0769231
floatShares 38.57M
sharesOutstanding 58.94M
sharesShort 3.81M
sharesShortPriorMonth 3.99M
dateShortInterest
sharesPercentSharesOut 0.06%
heldPercentInsiders 0.20%
heldPercentInstitutions 0.55%
Short Ratio help_outline 9.41%
shortPercentOfFloat 0.08%
impliedSharesOutstanding
bookValue 2.882
Price To Book help_outline 1.25
earningsQuarterlyGrowth
netIncomeToCommon -59.20M
trailingEps -1.27%
forwardEps -1.17%
enterpriseToEbitda -1.39
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.3 3Q 2024
institutionsCount 108
lastUpdated Sept. 16, 2024, 8:39 p.m.